Not applicableNot Yet RecruitingNCT07054047What this trial is testingImproving Diagnosis and Treatment for Patients With Rectal CancerWho this might be right forGI Cancer Imperial College London 438
Testing effectiveness (Phase 2)Study completedNCT00483834What this trial is testingA Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal CancerWho this might be right forColorectal Cancer University Health Network, Toronto 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07773363What this trial is testingRetlirafusp Alfa Plus Apatinib and Chemotherapy as Second-Line Treatment for Pancreatic CancerWho this might be right forPancreatic Cancer Tang-Du Hospital 37
Not applicableEnded earlyNCT03960021What this trial is testingImmune Mechanisms After Radiofrequency Ablation of Pulmonary Metastases From Colorectal Cancer OriginWho this might be right forImmune Evasion, TumorNeoplastic Cells, CirculatingCirculating Tumor Cell+2 more Institut Bergonié 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03785249What this trial is testingPhase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1Who this might be right forAdvanced CancerMetastatic CancerMalignant Neoplastic Disease Mirati Therapeutics Inc. 731
Early research (Phase 1)Study completedNCT03295084What this trial is testingSafety, Tolerability and Pharmacokinetics of Oral Tablet of Irinotecan in Adult Patients With Solid TumorsWho this might be right forMetastatic Colorectal Cancer Dorte Nielsen 39
Testing effectiveness (Phase 2)UnknownNCT01963702What this trial is testingA Phase II Trial of Exploring the Predictive Factors of TX and XELOX Regimen in the First Line Treatment of MGCWho this might be right forGastric Cancer Fudan University 120
Testing effectiveness (Phase 2)Study completedNCT01874665What this trial is testingTrial of Ponatinib in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal TumorWho this might be right forGIST Ariad Pharmaceuticals 45
Not applicableStudy completedNCT01405430What this trial is testingExploration of Circulating VE-cadherin in Metastatic Colorectal Adenocarcinoma Patients Treated With BevacizumabWho this might be right forColorectal CancerMetastasis Centre Leon Berard 63
Testing effectiveness (Phase 2)Active Not RecruitingNCT05205330What this trial is testingVorbipiprant (CR6086) / Balstilimab (AGEN2034) Combination in Stage IV Refractory pMMR - MSS CRC, and Other Metastatic GI CancersWho this might be right forRefractory Metastatic Colorectal CancerSolid TumorMetastatic Microsatellite-stable Colorectal Cancer+3 more Rottapharm Biotech 107
Early research (Phase 1)Study completedNCT00276302What this trial is testingSafety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS)Who this might be right forGastrointestinal Stromal TumorsSoft Tissue Sarcomas Infinity Pharmaceuticals, Inc. 63
Large-scale testing (Phase 3)Study completedNCT01001377What this trial is testingASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Amgen 1,010
Large-scale testing (Phase 3)Ended earlyNCT01956812What this trial is testingPhase 3 Trial of 90Y-Clivatuzumab Tetraxetan & Gemcitabine vs Placebo & Gemcitabine in Metastatic Pancreatic CancerWho this might be right forMetastatic Pancreatic CancerPancreatic Cancer Gilead Sciences 334
Testing effectiveness (Phase 2)UnknownNCT03662412What this trial is testingStudy of Sirolimus in Patients With Advanced Pancreatic CancerWho this might be right forPancreatic Cancer Second Affiliated Hospital, Zhejiang University, School of Medicine 36
Testing effectiveness (Phase 2)Ended earlyNCT00602329What this trial is testingMRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal CancerWho this might be right forColorectal Cancer Abramson Cancer Center at Penn Medicine 5
Testing effectiveness (Phase 2)UnknownNCT05970302What this trial is testingXELOX +Bev +Tislelizumab for First-line Treatment of MSS/pMMR RAS-mutated mCRCWho this might be right forTislelizumabBevacizumabOxaliplatin+5 more Cancer Institute and Hospital, Chinese Academy of Medical Sciences 52
Large-scale testing (Phase 3)UnknownNCT02854072What this trial is testingA Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer PatientsWho this might be right forPancreatic Cancer Samsung Pharmaceutical Co., Ltd. 148
Not applicableStudy completedNCT01196130What this trial is testingColorectal Cancer Umbrella Protocol - Assessment of Targeted Therapies Against Colorectal Cancer (ATTACC Program) Screening ProtocolWho this might be right forColorectal Cancer M.D. Anderson Cancer Center 1,275
Testing effectiveness (Phase 2)Ended earlyNCT05256381What this trial is testingSOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid TumorsWho this might be right forNon-Small Cell Lung CancerColorectal CancerCutaneous Squamous Cell Carcinoma+3 more SOTIO Biotech AG 166
Early research (Phase 1)Study completedNCT00291486What this trial is testingCapecitabine and 131I-huA33 in Patients With Metastatic Colorectal CancerWho this might be right forColorectal Neoplasms Ludwig Institute for Cancer Research 19